Can Patients with HER2-Low Breast Cancer Benefit from Anti-HER2 Therapies? A Review

Breast cancer (BC) poses a severe threat to the health of women worldwide. Currently, different therapeutic regimens are used for BC according to the pathological classification of HER2-positive or HER2-negative. Clinical reports of HER2-low expression indicate that the condition is HER2-negative, w...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jin, Liao, Dongying, Zhang, Xuemin, Miao, Changhong, Chen, Kuang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10128871/
https://www.ncbi.nlm.nih.gov/pubmed/37113514
http://dx.doi.org/10.2147/BCTT.S407181

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10128871/
https://www.ncbi.nlm.nih.gov/pubmed/37113514
http://dx.doi.org/10.2147/BCTT.S407181

Ejemplares similares